Results of first exposure of Type I diabetes patients to Oramed's oral insulin and of a first-in-humans study with its oral GLP-1 analog ... read more »
June 15, 2010
Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando FL, June 25-29, 2010
Oramed Pharmaceuticals to Present at the 9th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2010 ... read more »
June 2, 2010
Oramed Pharmaceuticals Forms Joint Venture -
Launches Entera Bio Ltd. ... read more »
May 26, 2010
Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism ... read more »
May 18, 2010
Oramed Pharmaceuticals announces that Dr. Michael Berelowitz, Senior Vice President of Pfizer, joins its Board of Directors ... read more »
May 6, 2010
Oramed Pharmaceuticals Reports Results in Phase 2b Trial of
Oral Insulin Administration to Type 2 Diabetes Patients ... read more »
March 25, 2010
Oramed Announces Completion of Pivotal Phase 2b Clinical Trials of it’s Oral Insulin Capsule, ORMD-0801 for Type 2 Diabetes ... read more »
February 16, 2010
Oramed Pharmaceuticals Expands Scientific Advisory Board with the Appointment of John Amatruda, M.D. ... read more »
February 10, 2010
Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland ... read more »
January 19, 2010
Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801 ... read more »
January 5, 2010
Oramed Pharmaceuticals to Present at OneMedPlace Finance Forum in San Francisco, California ... read more »